March 4, 2013 -
New Study Data Demonstrate Effectiveness of Back Treatment mild Over Two Year Period
The mild procedure, a minimally-invasive outpatient procedure designed to provide relief to patients suffering with the common back condition lumbar spinal stenosis (LSS), demonstrates durable pain relief and improvement in mobility over a two year period according to new study data.
- December 5, 2012 – Long Term Safety & Effectiveness of Back Treatment Called mild Demonstrated in New Systematic Safety Review
The mild procedure, a minimally-invasive outpatient procedure designed to provide relief to patients suffering with a common back condition, lumbar spinal stenosis (LSS), is safe and effective over the long term, according to a new comprehensive review published in the American Academy of Pain Medicine's Pain Medicine Journal.
- October 30, 2012 - Back Pain Treatment Called mild Cleared for European Use
The mild procedure, an innovative outpatient back-pain treatment from Vertos Medical Inc., has received approval to be marketed and sold throughout Europe. Vertos received the CE Mark this summer, which signifies that it has complied with all legal and safety requirements to sell its mild device kit in the 30 countries of the European Economic Area (27 European Union countries and 3 European Free Trade Association countries) plus Switzerland.
- October 17, 2012 - Back Pain Treatment Called mild Hits Milestone
The mild procedure, an innovative outpatient back-pain treatment, has passed a major milestone - more than 12,000 patients have received the treatment across the U.S. In addition, a growing number of clinical studies, including a recent trial published by the prestigious Cleveland Clinic, show that mild helps patients stand longer and walk farther with less pain over an extended period.
- July 11, 2011 - Vertos mild One-Year Post-Study Follow-up Data Published in Pain Practice Journal
Medical device company Vertos Medical Inc. has announced that one-year post-study follow-up data on its mild procedure for lumbar spinal stenosis (LSS) have been published in the peer-reviewed journal Pain Practice. In “Long Term Results of Percutaneous Lumbar Decompression mild for Spinal Stenosis,” authors concluded that the mild procedure is safe and provides long-term pain relief and improved mobility in patients with LSS.
- March 7, 2011 — Long-Term Post-Study Follow-Up And Single-Center Randomized Comparative Efficacy Study Results Demonstrate mild Safety, Efficacy
Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections (ESIs) for treating lumbar spinal stenosis (LSS).
*See data slides.
- November 22, 2010 — Vertos Medical's mild is Featured in Eight Clinical Presentations at the 2010 Annual Pain Medicine Meeting; Data Underscore Procedure and Device Safety and Efficacy
Medical device company Vertos Medical Inc. has announced that its mild procedure was the subject of eight clinical presentations at the American Society of Regional Anesthesia and Pain Medicine’s (ASRA) 2010 Annual Pain Medicine Meeting, November 18-21 in Phoenix.
- July 19, 2010 — Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos Medical's mild
Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS).
May 24, 2010 — MiDAS I Clinical Study Results Demonstrate Significant Improvement in Patients Treated with mild
Medical device company Vertos Medical, Inc. has announced the release of additional patient outcomes data from the MiDAS I1 (mild Decompression Alternative to open Surgery) trial, a prospective, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). As presented at the Florida Society of Interventional Pain Physicians (FSIPP) Annual Meeting in Orlando on May 23, investigators found that study participants reported statistically significant improvement in both their physical and mental well-being six weeks following the mild procedure.
- March 12, 2010 — Vertos Medical's Prospective Outcomes Study Demonstrates Efficacy, Validates Safety Profile of mild
Medical device company Vertos Medical, Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS). Six-week clinical data have shown that patients treated with mild experience statistically and clinically significant improvement in both pain and functional ability.
- February 24, 2010 — Acute Study Demonstrates Safety of Vertos Medical's mild Procedure; Findings Appear in Pain Physician Journal
Medical device company Vertos Medical Inc. has reported that an observational study on mild*, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS). The study, conducted by leading pain physicians Timothy Deer, M.D. (The Center for Pain Relief, Charleston, West Virgina) and Leonardo Kapural, M.D., Ph.D. (Cleveland Clinic, Cleveland, Ohio), found no reports of patient complications related to the mild devices or technique.
- January 21, 2010 — Vertos Medical Completes Enrollment in U.S. IRB I Study of mild, Unveils Comprehensive
Medical device company Vertos Medical Inc. has announced the completion of enrollment in its post-market U.S. IRB (Institutional Review Board) I Patient Outcomes Trial, a 75-patient study of the mild procedure.
October 20, 2009 — Vertos Medical Closes $15.5 Million Series D Financing
Medical device company Vertos Medical Inc., developer of the mild procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical
Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.